The CARDIO-TTRansform Study

is a Phase 3 clinical trial of an investigational medication called AKCEA-TTR-LRx for people living with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM).

Find out if CARDIO-TTRansform is right for you.

Study Icon

The Study arrow

Learn about how the CARDIO-TTRansform trial works.

Location Icon

Find a Study Site arrow

Enter your location to see all study sites near you.

Disease Icon

About ATTR-CM arrow

Read about ATTR-CM and current treatment options.